Pancytopenia caused by bone marrow aplasia in a horse.

The research is about a case where a mature Quarter Horse was found to suffer from Pancytopenia, a condition characterized by decreased number of blood cells, which was later diagnosed to be caused by bone marrow aplasia or the lack of bone marrow cells. The horse had a history of various drug administration prior to its condition, however, its health situation improved after being treated with glucocorticoids, androgens, and a type of antimicrobials that act against a wide range of bacteria.

Background and Aim of the Study

• The study focused on a case of Pancytopenia which was diagnosed in a mature Quarter Horse gelding.
• The aim was to identify the cause of the pancytopenia, conduct appropriate treatment, and observe the outcomes of the intervention.

Case Presentation and Diagnosis

• The horse was noted to have Pancytopenia, a condition of lower counts of all types of blood cells, i.e., red blood cells, white blood cells, and platelets.
• Lack of cells in the bone marrow, termed as bone marrow aplasia, was identified to be the cause of this condition.
• The horse, prior to this, had a medical history of administration of several drugs including penicillin, oxytetracycline, trimethoprim-sulfadiazine, phenylbutazone, dipyrone, flunixin meglumine, and isoxsuprine.

Treatment and Outcome

• After the diagnosis, an elaborate treatment was initiated, involving glucocorticoids, which are a class of steroid hormones; androgens, a group of hormones that control the development and maintenance of male characteristics; and broad-spectrum antimicrobials, that act against a wide range of disease-causing bacteria.
• Subsequent to the treatment, clinical remission was observed, indicating that the condition of the horse had significantly improved.